INS and type 1 diabetes mellitus: A case report from 2020 revealed some potential of fenofibrate by demonstrating maintained euglycaemia, without any insulin therapy, in a patient with newly diagnosed type 1 diabetes treated with a daily oral dose of fenofibrate initiated 7 days after diagnosis [8].